118 related articles for article (PubMed ID: 10630743)
1. Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure.
Azevedo ER; Newton GE; Parker AB; Floras JS; Parker JD
J Cardiovasc Pharmacol; 2000 Jan; 35(1):129-35. PubMed ID: 10630743
[TBL] [Abstract][Full Text] [Related]
2. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
Azevedo ER; Newton GE; Parker JD
J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.
Brunner-La Rocca HP; Kaye DM; Woods RL; Hastings J; Esler MD
J Am Coll Cardiol; 2001 Apr; 37(5):1221-7. PubMed ID: 11300426
[TBL] [Abstract][Full Text] [Related]
4. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure.
Azevedo ER; Newton GE; Floras JS; Parker JD
Circulation; 2000 May; 101(17):2053-9. PubMed ID: 10790346
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure.
Kaye DM; Jennings GL; Dart AM; Esler MD
J Am Coll Cardiol; 1998 Mar; 31(3):583-7. PubMed ID: 9502639
[TBL] [Abstract][Full Text] [Related]
6. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
Al-Hesayen A; Parker JD
Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
[TBL] [Abstract][Full Text] [Related]
7. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
8. Sympathoinhibitory effects of atrial natriuretic factor in normal humans.
Floras JS
Circulation; 1990 Jun; 81(6):1860-73. PubMed ID: 2140540
[TBL] [Abstract][Full Text] [Related]
9. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
10. Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure.
Abramson BL; Ando S; Notarius CF; Rongen GA; Floras JS
Circulation; 1999 Apr; 99(14):1810-5. PubMed ID: 10199876
[TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure.
Newton GE; Parker JD
Circulation; 1996 Dec; 94(12):3161-7. PubMed ID: 8989124
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.
Ehara S; Nakamura Y; Matsumoto K; Hasegawa T; Shimada K; Takagi M; Hanatani A; Izumi Y; Terashima M; Yoshiyama M
Heart Vessels; 2013 Sep; 28(5):596-605. PubMed ID: 23014927
[TBL] [Abstract][Full Text] [Related]
13. The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
Al-Hesayen A; Azevedo ER; Newton GE; Parker JD
J Am Coll Cardiol; 2002 Apr; 39(8):1269-74. PubMed ID: 11955843
[TBL] [Abstract][Full Text] [Related]
14. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
[TBL] [Abstract][Full Text] [Related]
15. Sympathoinhibitory effects of atrial natriuretic peptide in rats with heart failure.
Barrett CJ; Schultz HD
J Card Fail; 1999 Dec; 5(4):316-23. PubMed ID: 10634673
[TBL] [Abstract][Full Text] [Related]
16. Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.
Manolis AJ; Olympios C; Sifaki M; Handanis S; Bresnahan M; Gavras I; Gavras H
Hypertension; 1995 Nov; 26(5):719-24. PubMed ID: 7591009
[TBL] [Abstract][Full Text] [Related]
17. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M
Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.
Saito Y; Nakao K; Nishimura K; Sugawara A; Okumura K; Obata K; Sonoda R; Ban T; Yasue H; Imura H
Circulation; 1987 Jul; 76(1):115-24. PubMed ID: 2954723
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
